Cargando…
Surrogate biomarkers of outcome for wake-up ischemic stroke
BACKGROUND: Wake-up ischemic stroke (IS) has been usually excluded from acute stroke therapy options for being outside of the safe treatment window. We identified risk factors, and clinical or molecular biomarkers that could be therapeutic targets for wake-up stroke prevention, thus hopefully leadin...
Autores principales: | Hervella, Pablo, Alonso-Alonso, María Luz, Pérez-Mato, María, Rodríguez-Yáñez, Manuel, Arias-Rivas, Susana, López-Dequidt, Iria, Pumar, José M., Sobrino, Tomás, Campos, Francisco, Castillo, José, Iglesias-Rey, Ramón |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178818/ https://www.ncbi.nlm.nih.gov/pubmed/35681147 http://dx.doi.org/10.1186/s12883-022-02740-z |
Ejemplares similares
-
sTWEAK as Predictor of Stroke Recurrence in Ischemic Stroke Patients Treated With Reperfusion Therapies
por: Hervella, Pablo, et al.
Publicado: (2021) -
The Smoking Paradox in Stroke Patients Under Reperfusion Treatment Is Associated With Endothelial Dysfunction
por: Iglesias-Rey, Ramón, et al.
Publicado: (2022) -
Regulatory T cells participate in the recovery of ischemic stroke patients
por: Santamaría-Cadavid, María, et al.
Publicado: (2020) -
sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy
por: da Silva‐Candal, Andrés, et al.
Publicado: (2022) -
Temperature-Induced Changes in Reperfused Stroke: Inflammatory and Thrombolytic Biomarkers
por: Ávila-Gómez, Paulo, et al.
Publicado: (2020)